In a 45-year-old man with recurrent ischemic strokes, should an aggressive cardiac work‑up—including transesophageal echocardiography (TEE)—be performed to exclude a cardiogenic source of embolism?

Yes, aggressive cardiac investigation including TEE is strongly indicated in this 45-year-old man with recurrent ischemic strokes

In a 45-year-old patient with recurrent ischemic strokes, transesophageal echocardiography (TEE) should absolutely be performed as part of the diagnostic workup to identify potential cardioembolic sources, as younger stroke patients have a significantly higher diagnostic yield from cardiac imaging and this directly impacts treatment decisions.

Why This Patient Warrants Aggressive Cardiac Investigation

Age-Related Diagnostic Yield

The 2021 AHA/ASA guidelines explicitly recommend echocardiography in cryptogenic stroke patients to evaluate for cardiac sources of embolism 1. Research demonstrates that the number needed to test (NNT) to detect a cardiac source of embolism is only 6 in patients under 50 years, compared to 62 in patients over 70 years 2. This represents a 10-fold difference in diagnostic yield, making cardiac imaging particularly valuable in your 45-year-old patient.

Recurrent Strokes Elevate the Urgency

The recurrent nature of this patient's strokes further strengthens the indication for comprehensive cardiac evaluation. When strokes recur despite standard workup, identifying a cardioembolic source becomes critical for appropriate secondary prevention—potentially switching from antiplatelet to anticoagulation therapy.

TEE vs TTE: Why TEE is Superior

TEE Detects Sources Missed by TTE

TEE identifies potential cardiac embolic sources in approximately 40% of patients with normal transthoracic echocardiography (TTE), independent of age 3. In one study of 231 consecutive stroke/TIA patients, TEE detected cardiac sources in 55% overall, with 39% identified only on TEE and not on TTE 3.

Major Risk Factors Requiring Anticoagulation

Critically, TEE identified major risk factors warranting anticoagulation in 16% of all patients that were missed by TTE 3. The most common finding was left atrial appendage thrombus (16% of patients), which is virtually impossible to visualize adequately with TTE 3. The presence of a positive TEE finding was an independent predictor of treatment with oral anticoagulation (OR=2.48) 4.

Guideline Support for TEE

The 2021 AHA/ASA guidelines give a Class 2a recommendation (Level B-R evidence) for echocardiography with or without contrast in cryptogenic stroke patients 1. While the guidelines don't mandate TEE over TTE, the research evidence strongly supports TEE as superior, particularly when TTE is unrevealing 5, 3, 6.

Specific Cardiac Sources to Identify

TEE excels at detecting:

• Left atrial appendage thrombus (most common major finding requiring anticoagulation)
• Patent foramen ovale (PFO) with atrial septal aneurysm (most common overall finding, present in 6-34% of young stroke patients) 2, 7
• Aortic arch atheroma >4mm
• Valvular vegetations or masses
• Intracardiac tumors
• Complex aortic plaques

Clinical Predictors Favoring TEE in This Patient

Multivariate analysis identified predictors associated with finding cardioembolic sources on TEE 7:

• Infarction in multiple vascular territories (OR 4.13)
• Posterior circulation infarction (OR 2.11)
• Peripheral vascular disease (OR 2.57)

If your patient has any of these features, the yield of TEE increases further.

The Diagnostic Algorithm

1. Complete the basic workup first (per 2021 guidelines 1):

   • ECG to screen for atrial fibrillation
   • Brain imaging (CT or MRI) to confirm infarction
   • Carotid imaging (ultrasound, CTA, or MRA) if anterior circulation stroke
   • Blood tests (CBC, coagulation studies, glucose, HbA1c, lipids)

2. Perform TTE initially as a reasonable first step, but recognize its limitations

3. Proceed directly to TEE when:

   • TTE is normal or non-diagnostic
   • Patient is young (<50-55 years)
   • Strokes are recurrent
   • No other clear etiology identified (cryptogenic)
   • Multiple vascular territory involvement

4. Consider prolonged cardiac monitoring (mobile telemetry or implantable loop recorder) simultaneously to detect paroxysmal atrial fibrillation, which has a Class 2a recommendation 1

Common Pitfalls to Avoid

• Don't stop at TTE alone in young patients—TEE provides critical additional information in 40% of cases 3
• Don't delay TEE waiting for symptoms to recur—the diagnostic window is optimal when performed acutely
• Don't assume "cryptogenic" means "no cardiac source"—it often means inadequate cardiac investigation
• Don't forget that contrast-enhanced TTE or cardiac MRI can complement TEE in specific situations (e.g., LV thrombus detection) 1, 6

Impact on Treatment

Finding a cardioembolic source fundamentally changes management:

• Anticoagulation instead of antiplatelet therapy for sources like LAA thrombus, atrial fibrillation
• PFO closure consideration in selected young patients with PFO and atrial septal aneurysm
• Specific interventions for valvular disease, endocarditis, or cardiac tumors

The 2021 guidelines emphasize that diagnostic evaluation should be completed within 48 hours of symptom onset to guide optimal prevention strategies 1. In a 45-year-old with recurrent strokes, this timeline is critical.

Bottom line: This is absolutely a "stroke in the young" scenario requiring comprehensive cardiac evaluation. TEE should be performed unless there is a specific contraindication (severe esophageal disease, uncooperative patient, or clear alternative stroke etiology already identified with appropriate treatment initiated).